Skip to main content

Table 3 Timing of outcomes to be assessed

From: Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO)

 

Time point

Baseline

3 months

6 months

9 months

12 months

FENO

Smartinhaler® data

 

Respiratory case report form (current medication, recent asthma history and attacks, inhaler technique, etc.)

    

Asthma Control Test

Paediatric Asthma Quality of Life Questionnaire

   

Spirometry (FEV1) and height

Weight

   

Asthma attacks

Asthma-related healthcare and other related resource use

Mechanistic studies

 Bronchodilator response (optional)

    

 Skin prick testing (optional)

At any assessment

 Saliva for DNA extraction (optional)

At any assessment